Summit Trail Advisors’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-3,000
Closed -$214K 309
2021
Q3
$214K Buy
+3,000
New +$186K 0.02% 245
2018
Q3
Sell
-605
Closed -$9K 408
2018
Q2
$9K Buy
+605
New +$12K ﹤0.01% 437
2018
Q1
Sell
-744
Closed -$31K 1350
2017
Q4
$31K Buy
+744
New +$37.9K ﹤0.01% 932

Other funds holding PRTA

Summit Trail Advisors's PRTA Position: Q4 2021 in Review

Summit Trail Advisors sold out of Prothena Corp (PRTA) in Q4 2021, closing a stake of 3,000 shares — an estimated $214K sold.

Summit Trail Advisors first reported a position in PRTA in Q4 2017 and held it in 3 quarters. The position peaked at $214K in Q3 2021. 196 funds tracked by Wall St. Rank hold PRTA as of Q4 2021.

  • Summit Trail Advisors reported no remaining Prothena Corp position as of Q4 2021 after selling out during the quarter.
  • Summit Trail Advisors sold 3,000 Prothena Corp shares in Q4 2021, an estimated $214K.
  • Summit Trail Advisors first reported a position in Prothena Corp in Q4 2017 and held it in 3 quarters.
  • Summit Trail Advisors's Prothena Corp position peaked at $214K in Q3 2021.
  • 196 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2021.

Based on Summit Trail Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.